ICN bernimmt tschechische Biotech-Firma

Article Abstract:

Czech firm Vyzkumny Ustav Antibiotik a Biotransformacii (VUAB), which has 550 staff and a turnover of US$ 16.5mn (1997), has been acquired by ICN Pharmaceuticals of the USA. VUAB has a world market share of 10% for ephedrine and holds a patent for a technology to extract the substance from yeast cultures. The company also produces injectable antibiotics, infusion solutions and nyastine and has an export quota of about 50%. ICN is highly active in central and eastern Europe and already owns 11 companies with an added turnover of US$ 433mn in the region. *

Comment:

Acquires Czech Vyzkumny Ustav Antibiotik a Biotransformacii which holds a world mkt shr of 10% for ephedrine & a yeasts patent

Foreign operations, Czech Republic, ICN Pharmaceuticals Inc., Vyzkumny Ustav Antibiotik Biotransformacii

---

Haaqke bernimmt SWO Polymertechnik GmbH

Article Abstract:

SWO Polymertechnik GmbH, Krefeld, a leading producer and distributor of products for the determination of thermal and rheological characteristics of polymer materials, has been acquired by Gebr. Haake GmbH, Karlsruhe. Haake develops, produces and distributes instruments for the determination of rheological characteristics of liquids and for tempering in the laboratory sector. Haake aims to make use of SWO's know-how, while SWO's products can be distributed on a wider basis through Haake's international network. *

Comment:

Acquires SWO Polymertechnik specializing in prods for determination of heat & rheological characteristics of polymer mtrls

Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals, Test & Measuring Equip, Instrument industry (Equipment), SWO Polymertechnik GmbH, Gebr. Haake GmbH

---

GERMANY: PATHOGENESIS STRENGTHENS PRESENCE

Article Abstract:

The Seattle, US-based company Pathogenesis Corp is taking a just over 20% stake in its German distributor, Pulmopharm of Munich. The German company was set up in 1997. Pathogenesis launched its first products for the treatment of diseases of the respiratory tract in 1998. Now it is looking for further cooperation partners.

Pharmaceutical Preparation Manufacturing, Pharmaceutical Preparations, PathoGenesis Corp., PulmoPharm

Similar abstracts:

• Abstracts: Boehringer Ingelheim/Glaxo Wellcome kooperieren GERMANY/US: BOEHRINGER INGELHEIM, GENETRONICS. Boehringer Ingelheim investiert in Italien
• Abstracts: Monsanto/AHP may just be the latest. After the breakup: Monsanto, American Home Products call off plans to merge

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.